arrow
Back
D

Dong‐Wook Kim

uijeongbu eulji medical center

62H-index
604Paper Count
2.0WCitation Count
Published Papers 86
Publication Date
Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results
errLeukemia
IF13.4
err2026-07-16
err0
errOAAI
errJorge E. Cortes; Delphine Rea; Michael J. Mauro; Andreas Hochhaus; Dong-Wook Kim; Koji Sasaki; Fabian Lang; Michael C. Heinrich; Massimo Breccia; Michael Deininger; Yeow-Tee Goh; Jeroen J. W. M. Janssen; Moshe Talpaz; Valle Gómez García de Soria; Philipp le Coutre; Francois-Xavier Mahon; Daniel J. DeAngelo; Andrea Damon; Shruti Kapoor; Gessami Sanchez-Olle; Matthias Hoch; Nithya Agrawal; Sara Quenet; Timothy P. Hughes
errShare
errSave
BCR::ABL1 tyrosine kinase inhibitors induce ribosome collisions to activate ZAK-dependent ribotoxic stress and apoptosis in chronic myeloid leukemia
errLeukemia
IF13.4
err2026-03-30
err0
errOAAI
errJumin Park; Soo-Hyun Kim; Jongmin Park; Heeju Park; Hongtae Kim; Dong-Wook Kim; Chunghun Lim
errShare
errSave
Regulation of metabolic adaptation and leukemia progression by MUSASHI2-DEPTOR-KIF11 axis
errLeukemia
IF13.4
err2025-10-01
err0
PREAI
errTania Setiawan; Jabir Aliyu Muhammad; Nadya Marcellina; Lawrence Mario Wirawan; Nayoung Jun; Ita Novita Sari; Vivian G. Oehler; Dong-Wook Kim; Hyog Young Kwon
errShare
errSave
Microfluidic Single-Cell Drug Screening: Toward Personalized Precision Therapy in Chronic Myeloid Leukemia
err2025-09-20
err0
PREAI
errHwisu Jeon; Yukyung Park; Soo-Hyun Kim; Chang-Yeol Jung; Hongtae Kim; Eujin Um; Dong-Wook Kim; Taesung Kim
errShare
errSave
2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia
errLeukemia
IF13.4
err2025-07-11
err0
errOAAI
errJane F. Apperley; Dragana Milojkovic; Nicholas C. P. Cross; Henrik Hjorth-Hansen; Andreas Hochhaus; Hagop Kantarjian; Jeffrey H. Lipton; Hemant Malhotra; Dietger Niederwieser; Jerald Radich; Philippe Rousselot; Susanne Saussele; Charles A. Schiffer; Richard Silver; Simona Soverini; Leif Stenke; Anna Turkina; Luis Felipe Casado; Fausto Castagnetti; Francisco Cervantes; Richard E. Clark; Jorge Cortes; Michael Deininger; Timothy P. Hughes; Jeroen Janssen; Qian Jiang; Dong-Wook Kim; Richard A. Larson; Francois X. Mahon; Michael Mauro; Jiri Mayer; Franck E. Nicolini; Fabrizio Pane; Delphine Rea; Johan Richter; Gianantonio Rosti; Giuseppe Saglio; Rüdiger Hehlmann
errShare
errSave
Asciminib remained superior vs bosutinib in late-line CML-CP after nearly 4 years of follow-up in ASCEMBL
err2025-05-09
err0
errOAAI
errMichael J. Mauro; Yosuke Minami; Andreas Hochhaus; Elza Lomaia; Sergey Voloshin; Anna Turkina; Dong-Wook Kim; Jane F. Apperley; Jorge E. Cortes; Andre Abdo; Laura Maria Fogliatto; Dennis Dong Hwan Kim; Philipp le Coutre; Susanne Saussele; Mario Annunziata; Timothy P. Hughes; Naeem Chaudhri; Lynette Chee; Valentin García-Gutiérrez; Koji Sasaki; Carla Boquimpani; Shruti Kapoor; Noemi Espurz; Vishal Dhamal; Delphine Rea
errShare
errSave
KF1601, a dual inhibitor of BCR::ABL1 and FLT3, overcomes drug resistance in FLT3+ blast phase chronic myeloid leukemia
err2025-04-14
err0
errOAAI
errKwon, Hyun-Jin; Shin, Ji Eun; Khan, Amir; Park, So Yeon; Kim, Jiyoung; Lee, Jee-Young; Lee, Doohyun; Lee, Seungyeon; Im, Chun Young; Moon, Heegyum; Han, Ye Ri; Tamai, Minori; Akahane, Koshi; Inukai, Takeshi; Lee, Wonhwa; Kim, Hyelim; Kim, Hong Nam; Ahn, Sung-Min; Park, Hyun Woo; Kim, Dong-Wook
errShare
errSave
Continuous manufacturing and process analytical technology: focusing on dosage forms with improved solubility and controlled release
err2025-03-01
err0
PREAI
errSeok, Su Hyun; Yoo, Seung-Dong; Kim, Dong-Wook; Lee, In-Ah; Min, Kyung Hyun; Kang, Ji-Hyun; Park, Chun-Woong; Kim, Ju-Young; Park, Eun-Seok
errShare
errSave
Novel Microfluidic and AI-Based Approach for Personalized Drug Selection in Chronic Myeloid Leukemia (CML) Patients
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errJeon, Hwisu; Park, Yukyung; Um, Eujin; Kim, Hongtae; Jung, Chang-Yeol; Kim, Dong-Wook; Kim, Taesung
errShare
errSave
A line attractor encoding a persistent internal state requires neuropeptide signaling
errCELL
IF42.5
err2024-10-01
err5
errOAAI
errMountoufaris, George; Nair, Aditya; Yang, Bin; Kim, Dong-Wook; Vinograd, Amit; Kim, Samuel; Linderman, Scott W.; Anderson, David J.
errShare
errSave
REXO5 promotes genomic integrity through regulating R-loop using its exonuclease activity
errLEUKEMIA
IF13.4
err2024-07-30
err0
errOAAI
errLee, Ye Jin; Lee, Seo Yun; Kim, Soomi; Kim, Soo-Hyun; Lee, Soo Hyeon; Park, Sungho; Kim, Jae Jin; Kim, Dong-Wook; Kim, Hongtae
errShare
errSave
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results
errLEUKEMIA
IF13.4
err2024-05-16
err8
errOAAI
errCortes, Jorge E.; Sasaki, Koji; Kim, Dong-Wook; Hughes, Timothy P.; Etienne, Gabriel; Mauro, Michael J.; Hochhaus, Andreas; Lang, Fabian; Heinrich, Michael C.; Breccia, Massimo; Deininger, Michael; Goh, Yeow Tee; Janssen, Jeroen J. W. M.; Talpaz, Moshe; de Soria, Valle Gomez Garcia; le Coutre, Philipp; Deangelo, Daniel J.; Damon, Andrea; Cacciatore, Silvia; Polydoros, Fotis; Agrawal, Nithya; Rea, Delphine
errShare
errSave
Treatment of chronic-phase chronic myeloid leukemia in patients randomized to dasatinib or imatinib after suboptimal responses to 3 months of imatinib therapy: final 5-year results from DASCERN
err2024-05-02
err0
errOAAI
errCortes, Jorge E.; Jiang, Qian; Wang, Jianxiang; Weng, Jianyu; Zhu, Huanling; Liu, Xiaoli; Hochhaus, Andreas; Kim, Dong-Wook; Radich, Jerald; Savona, Michael; Martin-Regueira, Patricia; Sy, Oumar; Saglio, Giuseppe
errShare
errSave
Brain-Decellularized ECM-Based 3D Myeloid Sarcoma Platform: Mimicking Adaptive Phenotypic Alterations in the Brain
err2024-02-13
err1
PREAI
errYoon, Heejeong; Kang, Joo H.; Cho, Seung Woo; Park, Chun Gwon; Kim, Dong-Wook; Park, Tae-Eun
errShare
errSave
Effect of the interval between birth and second dose of hepatitis B vaccine on perinatal transmission of hepatitis B virus
err2023-11-13
err1
errOAAI
errYang, Tae Un; Vargas-Zambrano, Juan C.; Park, Hang A.; Jung, Chae Won; Kim, Dongwook; Jee, Youngmee
errShare
errSave
Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia
err2023-11-06
err3
errOAAI
errShin, Ji Eun; Kim, Soo-Hyun; Kong, Mingyu; Kim, Hwa-Ryeon; Yoon, Sungmin; Kee, Kyung-Mi; Kim, Jung Ah; Kim, Dong Hyeon; Park, So Yeon; Park, Jae Hyung; Kim, Hongtae; No, Kyoung Tai; Lee, Han-Woong; Gee, Heon Yung; Hong, Seunghee; Guan, Kun-Liang; Roe, Jae-Seok; Lee, Hyunbeom; Kim, Dong-Wook; Park, Hyun Woo
errShare
errSave
Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy results
errLEUKEMIA
IF13.4
err2023-03-22
err23
errOAAI
errMauro, Michael J.; Hughes, Timothy P.; Kim, Dong-Wook; Rea, Delphine; Cortes, Jorge E.; Hochhaus, Andreas; Sasaki, Koji; Breccia, Massimo; Talpaz, Moshe; Ottmann, Oliver; Minami, Hironobu; Goh, Yeow Tee; DeAngelo, Daniel J.; Heinrich, Michael C.; Gomez-Garcia de Soria, Valle; le Coutre, Philipp; Mahon, Francois-Xavier; Janssen, Jeroen J. W. M.; Deininger, Michael; Shanmuganathan, Naranie; Geyer, Mark B.; Cacciatore, Silvia; Polydoros, Fotis; Agrawal, Nithya; Hoch, Matthias; Lang, Fabian
errShare
errSave
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL
errLEUKEMIA
IF13.4
err2023-01-30
err64
errOAAI
errHochhaus, Andreas; Rea, Delphine; Boquimpani, Carla; Minami, Yosuke; Cortes, Jorge E.; Hughes, Timothy P.; Apperley, Jane F.; Lomaia, Elza; Voloshin, Sergey; Turkina, Anna; Kim, Dong-Wook; Abdo, Andre; Fogliatto, Laura Maria; le Coutre, Philipp; Sasaki, Koji; Kim, Dennis Dong Hwan; Saussele, Susanne; Annunziata, Mario; Chaudhri, Naeem; Chee, Lynette; Garcia-Gutierrez, Valentin; Kapoor, Shruti; Allepuz, Alex; Quenet, Sara; Bedoucha, Veronique; Mauro, Michael J.
errShare
errSave
errShare
errSave
Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committee (vol 15, 1, 2022)
err2022-03-23
err0
errOAAI
errJanuzzi, James L.; Garasic, Joseph M.; Kasner, Scott E.; McDonald, Vickie; Petrie, Mark C.; Seltzer, Jonathan; Mauro, Michael; Croce, Kevin; Berman, Ellin; Deininger, Michael; Hochhaus, Andreas; Pinilla-Ibarz, Javier; Nicolini, Franck; Kim, Dong-Wook; DeAngelo, Daniel J.; Kantarjian, Hagop; Xu, Jing; Hall, Tracey; Srivastava, Shouryadeep; Naranjo, Daniel; Cortes, Jorge
errShare
errSave